We are seeking an innovative and highly motivated Senior Systems Engineer who will make significant contributions to the development of our advanced cell therapy manufacturing platform.
Requirements
- Masters degree in Engineering, Physics or Biotech Automation, and at least one year of experience as Systems Engineer, Applications Engineer, R&D Engineer or Integration Engineer in a biotechnology field, including a year of experience with MATLAB or Python and working knowledge of at least one data visualization or statistical tool (e.g. JMP, Minitab or Tableau)
Skills Required
- Master's degree in Engineering, Physics, or Biotech Automation
- At least one year experience as Systems Engineer, Applications Engineer, R&D Engineer, or Integration Engineer in biotechnology
- At least one year experience with MATLAB or Python
- Working knowledge of at least one data visualization or statistical tool (e.g., JMP, Minitab, Tableau)
What We Do
Cellares is revolutionizing cell therapy manufacturing. We are developing a one-of-a-kind solution, The Cell Shuttle, to overcome the challenges associated with manufacturing so these life-saving therapies are affordable and widely available to patients who can benefit. The clinical impact of cell therapy in treating cancer has been proven, but this therapeutic approach has several limitations, especially in manufacturing, leaving extremely sick patients waiting for treatment and desperate for hope. Since cell therapy is currently produced for a single patient at a time, it is expensive to manufacture, requiring significant time and resources, and is difficult to scale. Preclinical and clinical scientists, as well as commercial cell therapy manufacturers also lack the options to fully automate their manufacturing process quickly, safely, cost-effectively and at the scale they need. The Cell Shuttle is an automated and closed end-to-end manufacturing solution that is flexible and scalable, enabling customers to run exact processes specified for their cell therapy. Compared with the current manual manufacturing processes for cell therapy, the Cell Shuttle’s next-generation automated manufacturing solution has 10 times the scalability (meaning 10 times more patient doses can be produced simultaneously), enables a three-fold reduction in process failure rates and will reduce the per-patient manufacturing cost by up to 70 percent for most processes.









